CSAI 10-Q filed 2026-11-16 | Key takeaways
CSAI filed its 10-Q; the most relevant disclosure change is expanded Nasdaq listing compliance risk: Stockholders' equity of approximately $2.3 million at September 30, 2026 is below the $2.5 million minimum Nasdaq listing requirement, and estimated MVLS of approximately $3.1 million is below the $5 million threshold (effectiveness stayed pending SEC review).
Key takeaways
Nasdaq compliance risk: Stockholders' equity of $2.3 million at September 30, 2026 is below the $2.5 million minimum requirement, and MVLS of approximately $3.1 million is below the $5 million threshold (effectiveness stayed pending SEC review).
Series 2 conversion price reduced to $3.47 per share under full-ratchet anti-dilution from $12.00 due to ATM sales and Exchange Note conversions below the original conversion price.
August 2026 option repricing: 378,705 underwater options repriced from $18.00-$202.50 to $4.97, generating $758k incremental compensation cost with $548k recognized in Q3 2026.
Series 2 Shares outstanding at September 30, 2026: 3,881 shares convertible into approximately 1.24 million Class A shares at $3.47 per share.
ATM Facility activity: Sold 207,656 shares for gross proceeds of $834k (weighted average $4.01 per share) during Q3 2026.
Subsequent events: October 2026 Exchange Note redemption delivered 18,246 shares, 95 Series 2 Shares converted delivering 30,407 shares, and ATM sold 28,879 additional shares reducing Series 2 conversion price to $2.55 per share.
Going concern: Cash of $2.2 million with $6.6 million net cash used in operations for nine months ended September 30, 2026; Equity Line expires November 25, 2026 without any draws.
Key metrics
Disclosure changes
- Nasdaq listing compliance risk
Stockholders' equity of approximately $2.3 million at September 30, 2026 is below the $2.5 million minimum Nasdaq listing requirement, and estimated MVLS of approximately $3.1 million is below the $5 million threshold (effectiveness stayed pending SEC review).
Delisting would trigger event of default under Exchange Note with Streeterville, potentially accelerating $1.1 million balance and increasing it by 10%. - Series 2 Shares conversion terms and anti-dilution
Series 2 conversion price reduced from $12.00 to $3.47 per share under full-ratchet anti-dilution provision due to ATM sales and Exchange Note conversions at prices below $12.00; 3,881 Series 2 Shares outstanding convertible into approximately 1.24 million Class A shares.
Continued share issuance below conversion price will further reduce conversion price, increasing potential dilution to common stockholders. - Derivative liability derecognition
Derivative liability balance is $0 as of September 30, 2026 following June 29, 2026 amendment eliminating variable conversion price feature that gave rise to compound embedded derivative.
No more fair value mark-to-market volatility from derivative liability; reduces non-cash earnings volatility. - Stock option repricing
August 27, 2026: Board implemented repricing of 378,705 Subject Options from $18.00-$202.50 to $4.97 per share, generating $758,254 incremental compensation cost with $548,147 recognized in Q3 2026; $210,107 unrecognized as of September 30, 2026 over weighted-average 2.0 years.
Repricing recognized significant non-cash compensation expense in Q3 2026 and will continue to do so through vesting period. - Operating lease right-of-use asset and liability
Operating lease right-of-use asset of $248,000 and operating lease liability of $250,000 ($64,000 current) recognized at September 30, 2026 for India subsidiary sub-lease (term ends October 2029) and Tulsa office lease (commenced October 5, 2026, expires October 31, 2028, payments approximately $42,000 over term).
New lease accounting entries reflect the company's expansion and real estate commitments. - Deemed dividend from down round feature
Q3 2026 deemed dividend of $2.59 million recognized from down round feature when Series 2 conversion price reduced from $12.00 to $3.47 per share; total nine months deemed dividends and dividends on preferred shares were $3.26 million versus $2.01 million in prior year period.
Large deemed dividends significantly reduce net loss available to common stockholders, impacting EPS.
Primary source
TickerStar generated this brief from an official company, investor-relations, earnings-call, or regulatory source. Review the primary material before making an investment decision.
Open SEC filingFollow CSAI in real time
Get material earnings, filing, IR, and earnings-call alerts by email.